Rufinamide Suspension
Product Images NDC 0054-0528

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 0054-0528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rufinamide Bottle Label

Label for Rufinamide Oral Suspension 40 mg/mL by Hikma Pharmaceuticals USA Inc. The label indicates a 460 mL bottle containing an oral suspension equivalent to 40 mg of rufinamide per mL. Instructions emphasize shaking before use, dispensing with an enclosed medication guide, and discarding within 90 days after opening. Storage temperature is specified as 20° to 25°C (68° to 77°F).*

FDA Label Image

Rufinamide Chem Structure

Chemical structure of Rufinamide is shown, depicting its molecular framework including a fluorinated benzene ring and a triazole ring attached to an amide group.*

FDA Label Image

Rufinamide Fig A

Illustration showing packaging components for Rufinamide oral suspension, 40 mg/mL. The image includes a labeled bottle, a box, a bottle adapter, and two oral dosing syringes, indicating the typical contents provided for dosing and administration.*

FDA Label Image

Rufinamide Fig B

An illustration showing a hand holding a bottle with a child-resistant cap, accompanied by an instruction to "shake well" indicated by a double-headed arrow above the bottle. This likely demonstrates proper handling for an oral suspension medication.*

FDA Label Image

Rufinamide Fig C

An instructional diagram labeled "bottle adapter" showing a simple outlined drawing of a bottle adapter component, likely intended for use with a medication bottle to facilitate dosing or administration.*

FDA Label Image

Rufinamide Fig D

An instructional illustration showing a hand holding an open bottle, with an arrow indicating the direction to press or push down on the bottle's shoulder. The image likely depicts a step in the process of opening or using the bottle.*

FDA Label Image

Rufinamide Fig E

An instructional diagram of an oral dosing syringe for administering Rufinamide suspension. The syringe is labeled with volume markings from 1 mL to 20 mL, with major markings at 5 mL intervals. The plunger is labeled for measurement control, intended for liquid medication dosing.*

FDA Label Image

Rufinamide Fig F

An instructional illustration showing a hand holding a syringe entering the opening of a bottle, indicating a step in drawing liquid medication from the bottle. A downward arrow beside the syringe suggests the direction of syringe insertion.*

FDA Label Image

Rufinamide Fig G

An instructional illustration showing a person using a syringe to withdraw a liquid medication from a bottle. The syringe is marked with volume measurements up to 20 mL, and an arrow points downward, indicating the direction of medication flow into the syringe.*

FDA Label Image

Rufinamide Fig H

An instructional line drawing showing how to measure liquid medication using an oral syringe. The image depicts a hand holding a syringe with volume markings up to 11 mL, emphasizing to measure the medication level to the white end of the plunger.*

FDA Label Image

Rufinamide Fig I

An instructional line drawing shows a person administering an oral suspension using a syringe. The syringe is positioned near the open mouth of the person to deliver the liquid medication.*

FDA Label Image

Rufinamide Fig J

An instructional illustration showing two steps of using a syringe oral dispenser. The left panel depicts pulling the syringe plunger upward while the syringe tip is in a cup, and the right panel shows pressing the plunger downward to dispense liquid from the syringe tip.*

FDA Label Image

Rufinamide Fig K

An instructional illustration showing a hand grasping and presumably twisting the cap of a bottle, demonstrating the proper way to open the bottle containing the oral suspension medication Rufinamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.